Even as it has filed for a compulsory licence for Covid-19 drug Baricitinib in India, Natco Pharma has already begun rolling out its generic version of the rheumatoid arthritis drug under the Barinat brand.
https://ift.tt/3nX0585
from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/2SyJQ5N
Popular Posts
-
India crossed the 98,000-mark in daily Covid-19 infections for the first time by recording 98,100 new cases on Wednesday, inching closer to ...
-
Triggered by coronavirus, mucormycosis, which has a mortality rate of over 50% and can lead to blindness, is sweeping through parts of Mahar...
-
The Taliban killed the Islamic State militant responsible for the suicide bombing that left 13 US troops and 170 Afghans dead at the Kabul a...
Recent Posts
Blog Archive
All the right reserved @ 2020-21 Glorries . Powered by Blogger.
0 Comments:
Post a Comment